Multi4 Medical's Bladder Cancer Treatment Study Published in BJU International
A first-in-human study by Multi4 Medical, published in BJU International, demonstrates the potential to shift bladder cancer treatment from the operating room to an outpatient setting.
Multi4 Medical has published clinical research in the British Journal of Urology International (BJUI), a prominent journal in the field of urology. The study details a novel approach to treating bladder cancer.
The peer-reviewed research indicates that the company's treatment can be administered in an outpatient clinic, allowing for complete treatment and diagnostic sampling in minutes on awake patients. This represents a shift from traditional surgical procedures.
The company has also commenced its first patient treatments in Europe using this technology. The therapy is intended for patients diagnosed with recurrent non-muscle-invasive bladder cancer (NMIBC).
This development could potentially improve patient outcomes and streamline the treatment process for bladder cancer, moving towards more accessible care.